Sheen Campbell R, Dear Amy, Brennan Stephen O
Molecular Pathology Laboratory, Department of Pathology, University of Otago, Christchurch, New Zealand.
Protein Expr Purif. 2010 Oct;73(2):184-8. doi: 10.1016/j.pep.2010.05.008. Epub 2010 May 16.
Mutations in the fibrinogen gene cluster can cause low plasma fibrinogen concentrations, known as hypofibrinogenaemia. It is important to verify whether a detected sequence variant in this cluster is deleterious or benign and this can be accomplished using protein expression systems. In this study, four mutations in the fibrinogen gammaC domain that had previously been described in patients with hypofibrinogenaemia were introduced into a gammaC construct and expressed in a Pichia pastoris yeast system to investigate their effects on protein stability and secretion. These experiments showed that the fibrinogen Middlemore (N230D), Dorfen (A289V), Mannheim II (H307Y), and Muncie (T371I) mutations were not secreted, supporting their causative role in hypofibrinogenaemia. Overexpression of the N230D, A289V and H307Y mutants revealed that the majority of the synthesised protein was retained in the endoplasmic reticulum, with only a minor proportion reaching the trans-Golgi network. Regardless, none of this protein was secreted which confirms that the four mutations investigated are indeed responsible for hypofibrinogenaemia.
纤维蛋白原基因簇中的突变可导致血浆纤维蛋白原浓度降低,即低纤维蛋白原血症。验证该基因簇中检测到的序列变异是有害的还是良性的很重要,这可以通过蛋白质表达系统来完成。在本研究中,将先前在低纤维蛋白原血症患者中描述的纤维蛋白原γC结构域中的四个突变引入γC构建体,并在毕赤酵母系统中表达,以研究它们对蛋白质稳定性和分泌的影响。这些实验表明,纤维蛋白原米德尔莫尔(N230D)、多尔芬(A289V)、曼海姆II(H307Y)和芒西(T371I)突变未被分泌,支持它们在低纤维蛋白原血症中的致病作用。N230D、A289V和H307Y突变体的过表达表明,大多数合成蛋白保留在内质网中,只有一小部分到达反式高尔基体网络。无论如何,这些蛋白均未分泌,这证实所研究的四个突变确实是低纤维蛋白原血症的病因。